Bright Minds Biosciences (DRUG) Operating Leases (2022 - 2025)

Bright Minds Biosciences' (DRUG) quarterly Operating Leases came in at $12006.9 in Q4 2025, down 84.76% YoY from $78792.1 in Q4 2024, and down 59.94% on a QoQ basis from $29973.0 in Q3 2025.

Bright Minds Biosciences (DRUG) Operating Leases (2022 - 2025) Analysis & Trends

Bright Minds Biosciences (DRUG) has 4 years of Operating Leases data on file, last reported at $12006.9 in Q4 2025.

  • Quarterly Operating Leases fell 84.76% year-over-year to $12006.9 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $12006.9 (down 84.76% YoY) and the FY2025 annual result came in at $29973.0, up 3.31% from the prior year.
  • Operating Leases declined to $12006.9 in Q4 2025, from $29973.0 in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $107276.2 in Q3 2022 to a low of $10434.2 in Q2 2023.
  • A 4-year average of $45047.0 and a median of $40197.5 in 2022 frame the typical range for Operating Leases.
  • The widest YoY moves for Operating Leases: up 3.31% in 2025, down 84.76% in 2025.
  • Tracing DRUG's Operating Leases over 4 years: stood at $40197.5 in 2022, then surged by 36.48% to $54862.4 in 2023, then surged by 43.62% to $78792.1 in 2024, then tumbled by 84.76% to $12006.9 in 2025.
  • The last three Operating Leases figures came in at $12006.9 (Q4 2025), $29973.0 (Q3 2025), and $45353.9 (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Bright Minds Biosciences 733.05 Mn 733.05 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 12,006.89
Sep 30, 2025 29,972.97
Jun 30, 2025 45,353.86
Mar 31, 2025 61,918.24
Dec 31, 2024 78,792.08
Sep 30, 2024 29,011.32
Sep 30, 2023 54,862.44
Jun 30, 2023 10,434.25
Mar 31, 2023 25,691.13
Dec 31, 2022 40,197.46
Sep 30, 2022 107,276.23